Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study

被引:0
|
作者
Shan Jin
Yun-Tian Yang
Wuyuntu Bao
Yinbao Bai
Jing-Wen Ai
Yousheng Liu
Hong Yong
机构
[1] Affiliated Hospital of Inner Mongolia Medical University,Department of General Surgery
[2] Affiliated Hospital of Inner Mongolia Medical University,Departments of Neurology
[3] Public Health School of Inner Mongolia Medical University,undefined
来源
Endocrine | 2019年 / 65卷
关键词
Differentiated thyroid carcinoma; TSH suppression therapy; Cognitive impairment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:327 / 337
页数:10
相关论文
共 50 条
  • [31] Relationship between serum lipid profile and thyroid function after thyroid hormone withdrawal in patients with differentiated thyroid carcinoma
    杜娜
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (02) : 19 - 20
  • [32] Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
    Gu, Yushen
    Xu, Hongrong
    Yang, Yanling
    Xiu, Yan
    Hu, Pengcheng
    Liu, Min
    Wang, Xiangqing
    Song, Jun
    Di, Yan
    Wang, Jian
    Zhang, Xiaoxia
    Xu, Tao
    Li, Xuening
    Shi, Hongcheng
    FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [33] Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer
    Altuntas, Seher Cetinkaya
    Hocaoglu, Cicek
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (10) : 683 - 691
  • [34] 2015 American Thyroid Association guidelines and thyroid-stimulating hormone suppression after thyroid lobectomy
    Reed, Robert
    Strumpf, Andrew
    Martz, Teresa G.
    Kavanagh, Kaitlin J.
    Fedder, Katherine L.
    Jameson, Mark J.
    Shonka, David C., Jr.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (02): : 639 - 644
  • [35] Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal
    Oyen, WJG
    Verhagen, C
    Saris, E
    van den Broek, WJM
    Pieters, GFFM
    Corstens, FHM
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (04) : 643 - 646
  • [36] A Prospective Study of the Effect of Radioiodine Therapy on Ovarian Reserve Function in Patients with Differentiated Thyroid Carcinoma
    Miao, W.
    Lin, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S143 - S143
  • [37] Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer
    Lee, Jun Choul
    Song, Byong-Sop
    Kang, Young Mi
    Kim, Yu-Ri
    Kang, Yea Eun
    Lee, Ju Hee
    Shong, Minho
    Yi, Hyon-Seung
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [38] Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma
    Moog, F
    Linke, R
    Manthey, N
    Tiling, R
    Knesewitsch, P
    Tatsch, K
    Hahn, K
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (12) : 1989 - 1995
  • [39] The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyroglobulin and antithyroglobulin antibody
    Zhao, Deshan
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [40] Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
    Lawal, Ismaheel O.
    Nyakale, Nozipho E.
    Harry, Lerwine M.
    Lengana, Thabo
    Mokgoro, Neo P.
    Vorster, Mariza
    Sathekge, Mike M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 222 - 227